Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.32)
# 1,006
Out of 4,711 analysts
188
Total ratings
51.38%
Success rate
0.93%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCR NovoCure | Upgrades: Outperform | $18 → $30 | $30.80 | -2.60% | 11 | Dec 2, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $80 → $60 | $59.40 | +1.01% | 3 | Nov 6, 2024 | |
| USB U.S. Bancorp | Maintains: In-Line | $51 → $54 | $47.92 | +12.69% | 4 | Oct 30, 2024 | |
| SYK Stryker | Maintains: Outperform | $380 → $384 | $364.60 | +5.32% | 9 | Oct 30, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 → $620 | $524.05 | +18.31% | 10 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $475 → $490 | $524.43 | -6.57% | 11 | Oct 18, 2024 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $183 → $185 | $170.23 | +8.68% | 5 | Oct 16, 2024 | |
| BLCO Bausch + Lomb | Upgrades: Outperform | $19 → $25 | $18.00 | +38.89% | 7 | Oct 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $113 → $110 | $107.12 | +2.69% | 12 | Oct 1, 2024 | |
| WAT Waters | Maintains: In-Line | $335 → $355 | $368.16 | -3.57% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $47.94 | +16.81% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $1,375 → $1,450 | $1,230.74 | +17.82% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $132.08 | +21.14% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $81.03 | +28.35% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $78 → $82 | $71.65 | +14.45% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $102 | $78.91 | +29.26% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $76 → $70 | $74.81 | -6.43% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $43.12 | +34.51% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $228.55 | +21.64% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $82 → $90 | $88.95 | +1.18% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $227.68 | +27.37% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $53 → $50 | $50.43 | -0.85% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $114.23 | +8.55% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $135 → $145 | $134.51 | +7.80% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $3.64 | +37.36% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $29.50 | +52.54% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $21.21 | +27.30% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $136.02 | +28.66% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $112.56 | +11.05% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.89 | +690.87% | 1 | May 31, 2022 |
NovoCure
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $30.80
Upside: -2.60%
Exact Sciences
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $60
Current: $59.40
Upside: +1.01%
U.S. Bancorp
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $47.92
Upside: +12.69%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $380 → $384
Current: $364.60
Upside: +5.32%
Thermo Fisher
Oct 24, 2024
Maintains: Outperform
Price Target: $630 → $620
Current: $524.05
Upside: +18.31%
Intuitive Surgical
Oct 18, 2024
Maintains: In-Line
Price Target: $475 → $490
Current: $524.43
Upside: -6.57%
J.B. Hunt Transport Services
Oct 16, 2024
Maintains: Outperform
Price Target: $183 → $185
Current: $170.23
Upside: +8.68%
Bausch + Lomb
Oct 15, 2024
Upgrades: Outperform
Price Target: $19 → $25
Current: $18.00
Upside: +38.89%
Zimmer Biomet Holdings
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $107.12
Upside: +2.69%
Waters
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $368.16
Upside: -3.57%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $47.94
Upside: +16.81%
Oct 1, 2024
Maintains: In-Line
Price Target: $1,375 → $1,450
Current: $1,230.74
Upside: +17.82%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $132.08
Upside: +21.14%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $81.03
Upside: +28.35%
Oct 1, 2024
Maintains: In-Line
Price Target: $78 → $82
Current: $71.65
Upside: +14.45%
Oct 1, 2024
Maintains: Outperform
Price Target: $98 → $102
Current: $78.91
Upside: +29.26%
Oct 1, 2024
Maintains: In-Line
Price Target: $76 → $70
Current: $74.81
Upside: -6.43%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $43.12
Upside: +34.51%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $228.55
Upside: +21.64%
Oct 1, 2024
Maintains: Outperform
Price Target: $82 → $90
Current: $88.95
Upside: +1.18%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $227.68
Upside: +27.37%
Oct 1, 2024
Maintains: In-Line
Price Target: $53 → $50
Current: $50.43
Upside: -0.85%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $114.23
Upside: +8.55%
Oct 1, 2024
Maintains: In-Line
Price Target: $135 → $145
Current: $134.51
Upside: +7.80%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $3.64
Upside: +37.36%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $29.50
Upside: +52.54%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $21.21
Upside: +27.30%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $136.02
Upside: +28.66%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $112.56
Upside: +11.05%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.89
Upside: +690.87%